<DOC>
	<DOCNO>NCT02091973</DOCNO>
	<brief_summary>The calcineurin inhibitor drug include cyclosporin tacrolimus well-known nephrotoxicity . However , drug essential kidney transplant especially high immunological risk . To date , however , alternative regimen use everolimus-based showing less toxicity tacrolimus-based regimen mechanism . Of note , study aim evaluate toxicity use microRNA profile detection everolimus-based tacrolimus-based immunosuppressive regimen kidney transplantation .</brief_summary>
	<brief_title>MicroRNA Expression Everolimus-based Versus Tacrolimus-based Regimens Kidney Transplantation</brief_title>
	<detailed_description>The author aim evaluate effect two regimen ( everolimus-based versus tacrolimus-based ) kidney transplantation recipient . Both regimen prescribe recipents low immunologicla risk . After informed consent , eligible recipient collect blood urine sample microRNA profile test study period .</detailed_description>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Patients give informed consent participate study Actual eGFR &gt; 2025 ml/min/1.73 m2 Multiorgan transplantation Pregnancy ABO incompatible blood group Second , third , fouth kidney transplantation HIV positive , active carrier infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>everolimus</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>kidney transplantation</keyword>
	<keyword>microRNA</keyword>
</DOC>